TY - JOUR
T1 - Author Correction
T2 - Global burden of amphetamine, cannabis, cocaine and opioid use in 204 countries, 1990–2023: a Global Burden of Disease Study (Nature Medicine, (2026), 32, 2, (527-544), 10.1038/s41591-025-04137-0)
AU - Kang, Jiseung
AU - Kim, Hyeon Jin
AU - Kim, Min Seo
AU - Zyoud, Sa’ed H.
AU - Zielińska, Magdalena
AU - Zhu, Bin
AU - Zhong, Anthony
AU - Zhang, Jingya
AU - Zhang, Haijun
AU - Zeariya, Mohammed G.M.
AU - Zanghì, Aurora
AU - Zakham, Fathiah
AU - Yusuf, Hadiza
AU - Yu, Chuanhua
AU - Yonemoto, Naohiro
AU - Yip, Paul
AU - Yin, Dehui
AU - Yesodharan, Renjulal
AU - Yahaya, Zwanden Sule
AU - Wilandika, Angga
AU - Wickramasinghe, Nuwan Darshana
AU - Wang, Shu
AU - Wang, Yuan Pang
AU - Walde, Mandaras Tariku
AU - Waheed, Yasir
AU - Vujcic, Isidora S.
AU - Vinayak, Manish
AU - Verras, Georgios Ioannis
AU - Vaziri, Siavash
AU - Vasankari, Tommi Juhani
AU - Varghese, Joe
AU - Eynde, Jef Van den
AU - Vaithinathan, Asokan Govindaraj
AU - Ullah, Atta
AU - Ullah, Saeed
AU - Udoakang, Aniefiok John
AU - Tumurkhuu, Munkhtuya
AU - Tualeka, Abdul Rohim
AU - Tsermpini, Evangelia Eirini
AU - Tsatsakis, Aristidis
AU - Tsai, Alexander C.
AU - Tromans, Samuel Joseph
AU - Duc, Nguyen Tran Minh
AU - Tran, Thang Huu
AU - Tovani-Palone, Marcos Roberto
AU - Torrado, Marco
AU - Todorovic, Jovana
AU - Tiruye, Tenaw Yimer
AU - Kayode, Gbenga A.
AU - Ali, Mohammed Usman
N1 - Publisher Copyright:
© The Author(s), under exclusive licence to Springer Nature America, Inc. 2026.
PY - 2026/7
Y1 - 2026/7
N2 - Correction to: Nature Medicinehttps://doi.org/10.1038/s41591-025-04137-0, published online 16 January 2026. In the original version of this article, errors and omissions were identified in the Competing Interests statements of several authors among the GBD 2023 Substance Use Collaborators. Following a comprehensive review of all competing interest declarations, corrections were required for nine authors. The competing interests statement for S. Afzal was incomplete. The statement has been amended to include grants or contracts from the Dean Office, Institute of Public Health Lahore. The competing interests statement for L. Monasta was incomplete. The statement has been amended to include support for the present manuscript from the Italian Ministry of Health to the Institute for Maternal and Child Health – IRCCS Burlo Garofolo, with payments made to the institution under project RC 34/2027; all outside the submitted work. The competing interests statement for J.P.S. was incomplete. The statement has been amended to include support for the present manuscript from the Portuguese Foundation for Science and Technology, including payment of salary under contract reference 2021.01789.CEECIND/CP1662/CT0014; all outside the submitted work. The competing interests statement for L.M.L.R.S. contained inaccuracies regarding the sources of grants or contracts. The statement has been corrected to accurately reflect support received from SPRINT – Sport Physical Activity and Health Research & Innovation Center, Polytechnic of Guarda, 6300-559 Guarda, Portugal and RISE–Health, Faculty of Health Sciences, University of Beira Interior, 6201-506 Covilhã, Portugal. The competing interests statement for J.A.S. was incomplete. The statement has been amended to include stock or stock options in Atyr Pharmaceuticals. The competing interests statement for A.C.T. contained an incorrect NIH grant number. The grant number has been corrected from K34DA061696 to K24DA061696. The competing interests statements for B. Oancea, K. Krishan, and I. N. Soyiri were omitted from the version of this article initially published. The statements have now been added and read as follows: “B.O. reports grants from the Core Program within the Romanian National Research, Development, and Innovation Plan 2022–2027, carried out with the support of MRID, project no. 23020101 (SIA-PRO), contract no. 7N/2022, and project PNRR-I8 no. 842027778, contract no. 760096. K. Krishan reports non-financial support from the UGC Centre of Advanced Study (CAS II), awarded to the Department of Anthropology, and support from the RUSA 2.0 grant awarded by the Ministry of Education to Panjab University, Chandigarh, India; all outside the submitted work. I.N.S. reports a leadership or fiduciary role in another board, society, committee, or advocacy group, paid or unpaid, as a trustee of the Citizens Advice Bureau for Hull & East Riding, United Kingdom.” These errors have now been corrected in the HTML and PDF versions of the article. No other parts of the article have been changed.
AB - Correction to: Nature Medicinehttps://doi.org/10.1038/s41591-025-04137-0, published online 16 January 2026. In the original version of this article, errors and omissions were identified in the Competing Interests statements of several authors among the GBD 2023 Substance Use Collaborators. Following a comprehensive review of all competing interest declarations, corrections were required for nine authors. The competing interests statement for S. Afzal was incomplete. The statement has been amended to include grants or contracts from the Dean Office, Institute of Public Health Lahore. The competing interests statement for L. Monasta was incomplete. The statement has been amended to include support for the present manuscript from the Italian Ministry of Health to the Institute for Maternal and Child Health – IRCCS Burlo Garofolo, with payments made to the institution under project RC 34/2027; all outside the submitted work. The competing interests statement for J.P.S. was incomplete. The statement has been amended to include support for the present manuscript from the Portuguese Foundation for Science and Technology, including payment of salary under contract reference 2021.01789.CEECIND/CP1662/CT0014; all outside the submitted work. The competing interests statement for L.M.L.R.S. contained inaccuracies regarding the sources of grants or contracts. The statement has been corrected to accurately reflect support received from SPRINT – Sport Physical Activity and Health Research & Innovation Center, Polytechnic of Guarda, 6300-559 Guarda, Portugal and RISE–Health, Faculty of Health Sciences, University of Beira Interior, 6201-506 Covilhã, Portugal. The competing interests statement for J.A.S. was incomplete. The statement has been amended to include stock or stock options in Atyr Pharmaceuticals. The competing interests statement for A.C.T. contained an incorrect NIH grant number. The grant number has been corrected from K34DA061696 to K24DA061696. The competing interests statements for B. Oancea, K. Krishan, and I. N. Soyiri were omitted from the version of this article initially published. The statements have now been added and read as follows: “B.O. reports grants from the Core Program within the Romanian National Research, Development, and Innovation Plan 2022–2027, carried out with the support of MRID, project no. 23020101 (SIA-PRO), contract no. 7N/2022, and project PNRR-I8 no. 842027778, contract no. 760096. K. Krishan reports non-financial support from the UGC Centre of Advanced Study (CAS II), awarded to the Department of Anthropology, and support from the RUSA 2.0 grant awarded by the Ministry of Education to Panjab University, Chandigarh, India; all outside the submitted work. I.N.S. reports a leadership or fiduciary role in another board, society, committee, or advocacy group, paid or unpaid, as a trustee of the Citizens Advice Bureau for Hull & East Riding, United Kingdom.” These errors have now been corrected in the HTML and PDF versions of the article. No other parts of the article have been changed.
UR - https://www.scopus.com/pages/publications/105042281933
U2 - 10.1038/s41591-026-04513-4
DO - 10.1038/s41591-026-04513-4
M3 - Comment/Letter to the editor
AN - SCOPUS:105042281933
SN - 1078-8956
VL - 32
SP - 2690
JO - Nature medicine
JF - Nature medicine
IS - 7
ER -